Thomas Waerner

1.1k total citations
13 papers, 866 citations indexed

About

Thomas Waerner is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Thomas Waerner has authored 13 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Oncology. Recurrent topics in Thomas Waerner's work include Protein purification and stability (6 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Biosimilars and Bioanalytical Methods (4 papers). Thomas Waerner is often cited by papers focused on Protein purification and stability (6 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Biosimilars and Bioanalytical Methods (4 papers). Thomas Waerner collaborates with scholars based in Germany, Austria and United States. Thomas Waerner's co-authors include Hartmut Beug, Martin Jechlinger, Andreas Weith, Norbert Kraut, Susanna K. Lüdemann, Elżbieta Janda, Stefan Grünert, Peter Seither, Thomas Brabletz and Martin Vanderlaan and has published in prestigious journals such as Cancer Cell, Oncogene and Experimental Cell Research.

In The Last Decade

Thomas Waerner

12 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Waerner Germany	10	636	306	150	130	84	13	866
Rosa I. Gallagher United States	15	413 0.6×	345 1.1×	184 1.2×	160 1.2×	83 1.0×	27	808
Andrea Rosner United States	12	569 0.9×	341 1.1×	310 2.1×	122 0.9×	56 0.7×	16	929
Tom Truong United States	8	709 1.1×	393 1.3×	231 1.5×	81 0.6×	115 1.4×	12	1.0k
Chun Sun China	17	578 0.9×	234 0.8×	238 1.6×	48 0.4×	132 1.6×	26	847
Lara Perryman United Kingdom	13	516 0.8×	170 0.6×	204 1.4×	47 0.4×	73 0.9×	19	850
Wendy Prime United Kingdom	17	662 1.0×	358 1.2×	279 1.9×	57 0.4×	107 1.3×	24	1.1k
Mikiko Takikita United States	14	406 0.6×	309 1.0×	158 1.1×	49 0.4×	75 0.9×	19	714
Ali Sak Germany	17	656 1.0×	313 1.0×	238 1.6×	151 1.2×	49 0.6×	33	908
Gaynor Davies United Kingdom	19	576 0.9×	351 1.1×	255 1.7×	41 0.3×	87 1.0×	22	1.0k
Satoko Yamamoto Japan	18	301 0.5×	213 0.7×	148 1.0×	119 0.9×	51 0.6×	35	648

Countries citing papers authored by Thomas Waerner

Since Specialization

Citations

This map shows the geographic impact of Thomas Waerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Waerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Waerner more than expected).

Fields of papers citing papers by Thomas Waerner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Waerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Waerner. The network helps show where Thomas Waerner may publish in the future.

Co-authorship network of co-authors of Thomas Waerner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Waerner. A scholar is included among the top collaborators of Thomas Waerner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Waerner. Thomas Waerner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Gaza‐Bulseco, Georgeen, Christine Grimaldi, Richard W. Hutchinson, et al.. (2025). Host Cell Protein Clinical Safety Risk Assessment—An Updated Industry Review. Biotechnology and Bioengineering. 122(11). 3229–3248.

Waerner, Thomas, et al.. (2025). Polysorbates degrading enzymes in biotherapeutics – a current status and future perspectives. Frontiers in Bioengineering and Biotechnology. 12. 1490276–1490276. 3 indexed citations

Palackal, Nisha, Fengqiang Wang, Georgeen Gaza‐Bulseco, et al.. (2021). “High‐risk” host cell proteins (HCPs): A multi‐company collaborative view. Biotechnology and Bioengineering. 118(8). 2870–2885. 106 indexed citations

Waldera-Lupa, Daniel M., et al.. (2021). Host cell protein detection gap risk mitigation: quantitative IAC-MS for ELISA antibody reagent coverage determination. mAbs. 13(1). 1955432–1955432. 11 indexed citations

Waldera-Lupa, Daniel M., Martin Vanderlaan, Thomas Schwab, et al.. (2019). Mass spectrometric evaluation of upstream and downstream process influences on host cell protein patterns in biopharmaceutical products. Biotechnology Progress. 35(3). e2788–e2788. 19 indexed citations

Vanderlaan, Martin, et al.. (2018). Experience with host cell protein impurities in biopharmaceuticals. Biotechnology Progress. 34(4). 828–837. 85 indexed citations

Waerner, Thomas, Dietmar Thurnher, & Kurt Krapfenbauer. (2010). The role of laboratory medicine in healthcare: quality requirements of immunoassays, standardisation and data management in prospective medicine. The EPMA Journal. 1(4). 619–626. 11 indexed citations

Svoboda, Barbara, et al.. (2008). Cellular repressor of E1A-stimulated genes is a bona fide lysosomal protein which undergoes proteolytic maturation during its biosynthesis. Experimental Cell Research. 314(16). 3036–3047. 31 indexed citations

Waerner, Thomas, et al.. (2007). A receptor-binding-based bioassay to determine the potency of a plasmid biopharmaceutical encoding VEGF-C. Analytical and Bioanalytical Chemistry. 389(7-8). 2109–2113. 4 indexed citations

10.

Waerner, Thomas, Annamaria Gal, Thomas Brabletz, et al.. (2006). ILEI: A cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell. 10(3). 227–239. 150 indexed citations

11.

Gotzmann, Josef, Andreas Fischer, Markus Zojer, et al.. (2006). A crucial function of PDGF in TGF-β-mediated cancer progression of hepatocytes. Oncogene. 25(22). 3170–3185. 171 indexed citations

12.

Jechlinger, Martin, Stefan Grünert, Elżbieta Janda, et al.. (2003). Expression profiling of epithelial plasticity in tumor progression. Oncogene. 22(46). 7155–7169. 231 indexed citations

13.

Waerner, Thomas, et al.. (2001). Human RERE is localized to nuclear promyelocytic leukemia oncogenic domains and enhances apoptosis.. PubMed. 12(4). 201–10. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact